[ad_1] Biotech company Biocon, on September 28, announced that the U.S. Food and Drug Administration (US FDA) has completed a surveillance inspection of its Active Pharmaceutical Ingredient (API) facility in Bengaluru. The inspection, which took place between September 23 and September 27, 2024, resulted in four observations by the regulatory body. Biocon has not disclosed […]
Headline
Tag: biocon bengaluru api facility
Back To Top